FY15 results on May 29, 2015
Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 29, 2015:1. To consider and approve the Company's Audited Financial Statements for the Year ended March 31, 2015.2. To Consider and recommend dividend, if any, on Equity Shares for the year ended March 31, 2015....15-05-2015